Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05101044 · ClinicalTrials.gov registry record · NA

Open Trial to Improve Retention in Care for Persons With HIV Who Use Substances

A NA study of HIV and Substance Use Disorders, sponsored by Brown University.

Completed
Registry status
NA
Development phase
8
Enrollment target
2
Study locations

NCT05101044: Completed NA study of HIV and Substance Use Disorders, sponsored by Brown University.

NCT05101044 is a NA study of HIV and Substance Use Disorders that has completed, run by Brown University. The registered enrollment target is 8 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05101044, a NA study of HIV and Substance Use Disorders, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
2
Study locations

Study Summary

The open trial will examine the feasibility and acceptability of a brief, empirically-supported acceptance-based behavioral therapy intervention to promote retention in care for out-of-care people with HIV who use substances.

Primary Outcome

The Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.

Interventions

  • BEHAVIORAL Acceptance-based Behavioral Therapy (ABBT) Intervention

Study Locations (2)

Rhode Island

  • The Miriam Hospital - Providence
  • Brown University - Providence

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2022-04-01
Est. Completion 2024-05-31
Phase NA
Brown University

231 total trials

What the finished NCT05101044 record still lists

NCT05101044 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Acceptance-based Behavioral Therapy (ABBT) Intervention is the first listed.

NCT05101044 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05101044 about?

NCT05101044 is a clinical study titled "Open Trial to Improve Retention in Care for Persons With HIV Who Use Substances". The open trial will examine the feasibility and acceptability of a brief, empirically-supported acceptance-based behavioral therapy intervention to promote retention in care for out-of-care people with HIV who use substances.

What is the current status of trial NCT05101044?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-04-01. Estimated completion is 2024-05-31.

What conditions does trial NCT05101044 study?

This clinical trial studies the following conditions: HIV, Substance Use Disorders.

What interventions are being tested in trial NCT05101044?

The interventions under investigation include: Acceptance-based Behavioral Therapy (ABBT) Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05101044?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05101044 being conducted?

This trial has 2 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05101044's enrollment target sits among peer trials

8 302nd of 303 higher than 1 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05101044, the US trial registry maintained by the National Library of Medicine. NCT05101044 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.